Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo
- PMID: 21231965
- DOI: 10.1111/j.1574-695X.2011.00782.x
Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo
Abstract
Protective antigen (PA) from Bacillus anthracis binds to cellular receptors, combines with lethal factor (LF) forming lethal toxin (LeTx), and facilitates the translocation of LF into the cytosol. LeTx is cytotoxic for J774A.1 cells, a murine macrophage cell line, and causes death of Fisher 344 rats when injected intravenously. PA is also the major protective component in anthrax vaccines. Antibody-dependent enhancement has been reported for several viral diseases, a bacterial infection, and for B. anthracis LeTx in vitro cytotoxicity. Further screening of our 73 PA monoclonal antibodies (mAbs) identified a total of 17 PA mAbs that enhanced in vitro cytotoxicity at suboptimal concentrations of LeTx. A competitive binding enzyme-linked immunosorbent assay showed that these 17 PA mAbs identified eight different antigenic regions on PA. Eight of the 17 PA mAbs that enhanced LeTx in vitro cytoxicity were examined for their activity in vivo. Of the eight mAbs that were injected intravenously with a sublethal concentration of LeTx into male Fisher 344 rats, four mAbs enhanced the lethality of LeTx and resulted in the death of animals, whereas control animals did not succumb to intoxication. This is the first demonstration that PA mAbs can enhance LeTx intoxication in vivo.
FEMS Immunology & Medical Microbiology © 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. No claim to original US government works.
Similar articles
-
Differential susceptibility of macrophage cell lines to Bacillus anthracis-Vollum 1B.Toxicol In Vitro. 2005 Mar;19(2):221-9. doi: 10.1016/j.tiv.2004.08.007. Toxicol In Vitro. 2005. PMID: 15649636
-
Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis.J Infect Dis. 2005 Feb 1;191(3):422-34. doi: 10.1086/427189. Epub 2004 Dec 22. J Infect Dis. 2005. PMID: 15633102
-
Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages.Infect Immun. 2004 Jun;72(6):3276-83. doi: 10.1128/IAI.72.6.3276-3283.2004. Infect Immun. 2004. PMID: 15155630 Free PMC article.
-
Molecular basis for improved anthrax vaccines.Adv Drug Deliv Rev. 2005 Jun 17;57(9):1266-92. doi: 10.1016/j.addr.2005.01.028. Epub 2005 Apr 21. Adv Drug Deliv Rev. 2005. PMID: 15935874 Review.
-
Monoclonal antibody therapies against anthrax.Toxins (Basel). 2011 Aug;3(8):1004-19. doi: 10.3390/toxins3081004. Epub 2011 Aug 15. Toxins (Basel). 2011. PMID: 22069754 Free PMC article. Review.
Cited by
-
Analysis of defined combinations of monoclonal antibodies in anthrax toxin neutralization assays and their synergistic action.Clin Vaccine Immunol. 2012 May;19(5):731-9. doi: 10.1128/CVI.05714-11. Epub 2012 Mar 21. Clin Vaccine Immunol. 2012. PMID: 22441391 Free PMC article.
-
Bacillus anthracis edema factor substrate specificity: evidence for new modes of action.Toxins (Basel). 2012 Jul;4(7):505-35. doi: 10.3390/toxins4070505. Epub 2012 Jul 6. Toxins (Basel). 2012. PMID: 22852066 Free PMC article. Review.
-
Biochip for the Detection of Bacillus anthracis Lethal Factor and Therapeutic Agents against Anthrax Toxins.Membranes (Basel). 2016 Jun 24;6(3):36. doi: 10.3390/membranes6030036. Membranes (Basel). 2016. PMID: 27348008 Free PMC article.
-
Specific egg yolk immunoglobulin as a promising non-antibiotic biotherapeutic product against Acinetobacter baumannii pneumonia infection.Sci Rep. 2021 Jan 21;11(1):1914. doi: 10.1038/s41598-021-81356-8. Sci Rep. 2021. PMID: 33479293 Free PMC article.
-
Subdominant Outer Membrane Antigens in Anaplasma marginale: Conservation, Antigenicity, and Protective Capacity Using Recombinant Protein.PLoS One. 2015 Jun 16;10(6):e0129309. doi: 10.1371/journal.pone.0129309. eCollection 2015. PLoS One. 2015. PMID: 26079491 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical